Company Filing History:
Years Active: 2015
Title: Brian Dymock: Innovator in Pharmaceutical Chemistry
Introduction
Brian Dymock is a notable inventor based in Singapore, SG. He has made significant contributions to the field of pharmaceutical chemistry. Although he currently holds no patents, his work has focused on developing innovative compounds with potential medical applications.
Latest Patents
Brian Dymock's latest patents include two notable inventions. The first is a citrate salt of a compound identified as 9E-15-(2-Pyrrolidin-1-Yl-Ethoxy)-7,12,25-Trioxa-19,21,24-Triaza-TETRACYCLO[18.3.1.1(2,5).1(14,18)]HEXACOSA-1(24),2,4,9,14,16,18(26),20,22-Nonaene. This invention relates to certain salts that exhibit improved properties and includes pharmaceutical compositions for treating specific medical conditions. The second patent is for a citrate salt of 11-(2-Pyrrolidin-1-Yl-Ethoxy)-14,19-Dioxa-5,7,26-Triaza-TETRACYCLO[19.3.1.1(2,6).1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-Decaene. Similar to the first, this invention also focuses on improved properties and methods of use in medical treatments.
Career Highlights
Throughout his career, Brian Dymock has worked with several prominent companies in the pharmaceutical industry. He has been associated with Cti Biopharma Corp. and Tragara Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Brian has collaborated with notable colleagues, including Cheng Hsia Lee and Anthony Deodaunia William. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Brian Dymock is an innovative inventor whose work in pharmaceutical chemistry has the potential to impact medical treatments significantly. His focus on developing new compounds demonstrates his commitment to advancing healthcare solutions.